Clinical Utility of Stress Echocardiography in Remote Indigenous and Non-Indigenous Populations: A 10-Year Study in Central Australia.


Journal

Heart, lung & circulation
ISSN: 1444-2892
Titre abrégé: Heart Lung Circ
Pays: Australia
ID NLM: 100963739

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 29 08 2019
revised: 07 03 2020
accepted: 01 04 2020
pubmed: 27 6 2020
medline: 13 5 2021
entrez: 27 6 2020
Statut: ppublish

Résumé

Remote Central Australia has a large Indigenous population and a significant burden of cardiovascular disease. Stress echocardiography has been previously validated as a useful investigation for long-term prognostication. However, there are no prior studies assessing its utility in remote or Indigenous populations. Consecutive individuals undergoing stress echocardiography in Central Australia between 2007 and 2017 were included. Stress echocardiography was performed and reported via standard protocols. Individuals were followed up for all-cause mortality. One-thousand and eight patients (1,008) (54% Indigenous Australian) were included. After a mean follow-up of 3.5±2.4 years, 54 (5%) patients were deceased. Overall, 797 (79%) patients had no abnormalities during rest or stress echocardiography, with no difference according to ethnicity (p>0.05). In patients with a normal test, annual mortality averaged 1.3% over 5 years of follow-up, with annual mortality significantly higher in Indigenous compared to non-Indigenous individuals (1.8% vs 0.6% respectively). In those with an abnormal test, annual mortality was 4.4% vs 1.3% in Indigenous and non-Indigenous individuals respectively. Increasing age, Indigenous ethnicity and cardiometabolic comorbidities were associated with mortality in univariate analyses (p<0.05 for all). In multivariate models, only chronic kidney disease remained predictive of mortality, with other associations (including Indigenous ethnicity) becoming attenuated. This is the first study to report on the use of stress echocardiography in a remote or Indigenous population. A normal stress echocardiogram in remote Indigenous individuals was able to identify a lower risk group of patients in this setting. Although Indigenous individuals with a normal test still had a higher annual rate of mortality compared to non-Indigenous individuals, this association appeared to be mediated by cardiometabolic comorbidities.

Sections du résumé

BACKGROUND BACKGROUND
Remote Central Australia has a large Indigenous population and a significant burden of cardiovascular disease. Stress echocardiography has been previously validated as a useful investigation for long-term prognostication. However, there are no prior studies assessing its utility in remote or Indigenous populations.
METHOD METHODS
Consecutive individuals undergoing stress echocardiography in Central Australia between 2007 and 2017 were included. Stress echocardiography was performed and reported via standard protocols. Individuals were followed up for all-cause mortality.
RESULTS RESULTS
One-thousand and eight patients (1,008) (54% Indigenous Australian) were included. After a mean follow-up of 3.5±2.4 years, 54 (5%) patients were deceased. Overall, 797 (79%) patients had no abnormalities during rest or stress echocardiography, with no difference according to ethnicity (p>0.05). In patients with a normal test, annual mortality averaged 1.3% over 5 years of follow-up, with annual mortality significantly higher in Indigenous compared to non-Indigenous individuals (1.8% vs 0.6% respectively). In those with an abnormal test, annual mortality was 4.4% vs 1.3% in Indigenous and non-Indigenous individuals respectively. Increasing age, Indigenous ethnicity and cardiometabolic comorbidities were associated with mortality in univariate analyses (p<0.05 for all). In multivariate models, only chronic kidney disease remained predictive of mortality, with other associations (including Indigenous ethnicity) becoming attenuated.
CONCLUSION CONCLUSIONS
This is the first study to report on the use of stress echocardiography in a remote or Indigenous population. A normal stress echocardiogram in remote Indigenous individuals was able to identify a lower risk group of patients in this setting. Although Indigenous individuals with a normal test still had a higher annual rate of mortality compared to non-Indigenous individuals, this association appeared to be mediated by cardiometabolic comorbidities.

Identifiants

pubmed: 32586728
pii: S1443-9506(20)30239-0
doi: 10.1016/j.hlc.2020.04.013
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1808-1814

Informations de copyright

Crown Copyright © 2020. Published by Elsevier B.V. All rights reserved.

Auteurs

Seshika Ratwatte (S)

University of Newcastle, Concord Repatriation and General Hospital, and Royal Prince Alfred Hospital, Sydney, NSW, Australia.

Benedict Costello (B)

Baker IDI Heart & Diabetes Institute and Alfred Hospital, Melbourne, Vic, Australia.

Nadarajah Kangaharan (N)

Department of Cardiology, Alice Springs Hospital, Alice Springs, NT, Australia.

Katrina Bolton (K)

Department of Cardiology, Alice Springs Hospital, Alice Springs, NT, Australia.

Amrina Kaur (A)

Department of Cardiology, Alice Springs Hospital, Alice Springs, NT, Australia.

Wendy Corkill (W)

Department of Cardiology, Alice Springs Hospital, Alice Springs, NT, Australia.

Bernhard Kuepper (B)

Department of Cardiology, Alice Springs Hospital, Alice Springs, NT, Australia.

Bradley Pitman (B)

University of Adelaide, Royal Adelaide Hospital, and South Australian Health & Medical Research Institute, Adelaide, SA, Australia.

Prashanthan Sanders (P)

University of Adelaide, Royal Adelaide Hospital, and South Australian Health & Medical Research Institute, Adelaide, SA, Australia.

Christopher X Wong (CX)

University of Adelaide, Royal Adelaide Hospital, and South Australian Health & Medical Research Institute, Adelaide, SA, Australia. Electronic address: c.wong@adelaide.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH